Source: Oncology Nurse Advisor, June 2025
Overall survival (OS) in women with genital tract melanoma (GTM) is improved with immunotherapy, according to study findings published in Melanoma Research.
Data on the use of immunotherapy for mucosal melanomas overall has been lacking. As GTM in women is a rare condition, research regarding effective treatment in this patient population has been even more limited. Therefore, investigators explored the impact of immunotherapy on OS among women with GTM in the United States, as well as factors associated with OS.